NCT00618956 - A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring | Biotech Hunter

Enrollment

321

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2008

Conditions

Fibromyalgia

Interventions

DRUG

Milnacipran hydrochloride

Milnacipran 100 to 200 mg/day tablet (administered in divided doses, twice daily \[BID\]), oral administration.

DRUG

Placebo

Trial Locations (38)

13057

Site #005, East Syracuse

13623

Site #017, Toledo

14618

Site #010, Rochester

17055

Site #026, Mechanicsburg

23294

Site #020, Richmond

27103

Site #022, Winston-Salem

28209

Site #029, Charlotte

29651

Site #014, Greer

30328

Site #006, Atlanta

32216

Site #025, Jacksonville

32806

Site #011, Orlando

33484

Site #037, Delray Beach

33614

Site #036, Tampa

34471

Site #009, Ocala

35205

Site #032, Birmingham

35209

Site #035, Birmingham

37203

Site #031, Nashville

37620

Site #027, Bristol

38119

Site #024, Memphis

44122

Site #002, Cleveland

46254

Site #034, Indianapolis

47713

Site #018, Evansville

53406

Site #033, Racine

60048

Site #030, Libertyville

65807

Site #013, Springfield

77479

Site #028, Sugarland

84102

Site #003, Salt Lake City

85004

Site #038, Phoenix

87108

Site #021, Albuquerque

92117

Site #016, San Diego

93449

Site #019, Pismo Beach

94598

Site #008, Walnut Creek

97401

Site #023, Eugene

97404

Site #007, Eugene

97501

Site #001, Medford

98226

Site #015, Bellingham

01610

Site #004, Worchester

05091

Site #012, Woodstock